Global Peripheral Artery Disease Market
Global Peripheral Artery Disease Market

Peripheral Artery Disease Comprehensive Study by Type (Peripheral Angioplasty Balloons,, Peripheral Stents,, Peripheral Catheters,, Inferior Vena Cava (IVC), Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories, Balloon Inflation Devices), Filters (Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2026

Peripheral Artery Disease Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 217 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Peripheral Artery Disease Market Overview:
Peripheral artery disease (PAD) is a common circulatory problem in which narrowed arteries reduce blood flow to limbs. PAD usually affects arteries in the legs and sometimes affect the arteries that carry blood from heart to head, arms, kidneys, and stomach. It is caused by deposition of fats (plaques) in the artery walls, which reduces the blood flow to organs, limbs, and head. Production interruptions of PAD devices and delays in procedures from hospitals due to COVID-19 pandemic is expected to effect the growth of Peripheral Artery Disease Market. Some of the players profiled in the study are Abbott Laboratories (United States), AngioDynamics (United States), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), BIOTRONIK (Germany), Cook Medical (United States), Cardinal Health, Inc. (United States), Koninklijke Philips N.V (Netherlands) and TERUMO CORPORATION. (Japan).

On the basis of geography, the market of Peripheral Artery Disease has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Filters, the sub-segment i.e. Plaque Modification Devices will boost the Peripheral Artery Disease market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Peripheral Artery Disease market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers
  • Growth in geriatric population and an increase in the prevalence of peripheral artery disease
  • Introduction of advanced interventional products
  • Improved insurance and reimbursement policies

Influencing Trend
  • Improvement of healthcare infrastructure in developing countries

Restraints
  • Stringent approval process for stents

Opportunities
  • Market opportunities in developing countries




The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Target Audience:
Drugs Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Peripheral Artery Disease market on the basis of product [Peripheral Angioplasty Balloons,, Peripheral Stents,, Peripheral Catheters,, Inferior Vena Cava (IVC), Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories and Balloon Inflation Devices] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Peripheral Artery Disease market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Peripheral Artery Disease industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Peripheral Artery Disease market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Report Objectives / Segmentation Covered
By Type
  • Peripheral Angioplasty Balloons,
  • Peripheral Stents,
  • Peripheral Catheters,
  • Inferior Vena Cava (IVC)
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories
  • Balloon Inflation Devices
By Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories

By End User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in geriatric population and an increase in the prevalence of peripheral artery disease
      • 3.2.2. Introduction of advanced interventional products
      • 3.2.3. Improved insurance and reimbursement policies
    • 3.3. Market Trends
      • 3.3.1. Improvement of healthcare infrastructure in developing countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Peripheral Artery Disease, by Type, Filters, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Peripheral Artery Disease (Value)
      • 5.2.1. Global Peripheral Artery Disease by: Type (Value)
        • 5.2.1.1. Peripheral Angioplasty Balloons,
        • 5.2.1.2. Peripheral Stents,
        • 5.2.1.3. Peripheral Catheters,
        • 5.2.1.4. Inferior Vena Cava (IVC)
        • 5.2.1.5. Plaque Modification Devices
        • 5.2.1.6. Hemodynamic Flow Alteration Devices
        • 5.2.1.7. Peripheral Accessories
        • 5.2.1.8. Balloon Inflation Devices
      • 5.2.2. Global Peripheral Artery Disease by: Filters (Value)
        • 5.2.2.1. Plaque Modification Devices
        • 5.2.2.2. Hemodynamic Flow Alteration Devices
        • 5.2.2.3. Peripheral Accessories
      • 5.2.3. Global Peripheral Artery Disease by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Peripheral Artery Disease Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Peripheral Artery Disease: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AngioDynamics (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boston Scientific Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BIOTRONIK (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cook Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cardinal Health, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Koninklijke Philips N.V (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. TERUMO CORPORATION. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Peripheral Artery Disease Sale, by Type, Filters, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Peripheral Artery Disease (Value)
      • 7.2.1. Global Peripheral Artery Disease by: Type (Value)
        • 7.2.1.1. Peripheral Angioplasty Balloons,
        • 7.2.1.2. Peripheral Stents,
        • 7.2.1.3. Peripheral Catheters,
        • 7.2.1.4. Inferior Vena Cava (IVC)
        • 7.2.1.5. Plaque Modification Devices
        • 7.2.1.6. Hemodynamic Flow Alteration Devices
        • 7.2.1.7. Peripheral Accessories
        • 7.2.1.8. Balloon Inflation Devices
      • 7.2.2. Global Peripheral Artery Disease by: Filters (Value)
        • 7.2.2.1. Plaque Modification Devices
        • 7.2.2.2. Hemodynamic Flow Alteration Devices
        • 7.2.2.3. Peripheral Accessories
      • 7.2.3. Global Peripheral Artery Disease by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Peripheral Artery Disease Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Peripheral Artery Disease: by Type(USD Million)
  • Table 2. Peripheral Artery Disease Peripheral Angioplasty Balloons, , by Region USD Million (2015-2020)
  • Table 3. Peripheral Artery Disease Peripheral Stents, , by Region USD Million (2015-2020)
  • Table 4. Peripheral Artery Disease Peripheral Catheters, , by Region USD Million (2015-2020)
  • Table 5. Peripheral Artery Disease Inferior Vena Cava (IVC) , by Region USD Million (2015-2020)
  • Table 6. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2015-2020)
  • Table 7. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2015-2020)
  • Table 8. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2015-2020)
  • Table 9. Peripheral Artery Disease Balloon Inflation Devices , by Region USD Million (2015-2020)
  • Table 10. Peripheral Artery Disease: by Filters(USD Million)
  • Table 11. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2015-2020)
  • Table 12. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2015-2020)
  • Table 13. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2015-2020)
  • Table 14. Peripheral Artery Disease: by End User(USD Million)
  • Table 15. Peripheral Artery Disease Hospitals , by Region USD Million (2015-2020)
  • Table 16. Peripheral Artery Disease Clinics , by Region USD Million (2015-2020)
  • Table 17. Peripheral Artery Disease Others , by Region USD Million (2015-2020)
  • Table 18. South America Peripheral Artery Disease, by Country USD Million (2015-2020)
  • Table 19. South America Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 20. South America Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 21. South America Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 22. Brazil Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 23. Brazil Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 24. Brazil Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 25. Argentina Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 26. Argentina Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 27. Argentina Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 28. Rest of South America Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 29. Rest of South America Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 30. Rest of South America Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 31. Asia Pacific Peripheral Artery Disease, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 34. Asia Pacific Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 35. China Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 36. China Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 37. China Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 38. Japan Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 39. Japan Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 40. Japan Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 41. India Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 42. India Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 43. India Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 44. South Korea Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 45. South Korea Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 46. South Korea Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 47. Taiwan Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 48. Taiwan Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 49. Taiwan Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 50. Australia Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 51. Australia Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 52. Australia Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 56. Europe Peripheral Artery Disease, by Country USD Million (2015-2020)
  • Table 57. Europe Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 58. Europe Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 59. Europe Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 60. Germany Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 61. Germany Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 62. Germany Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 63. France Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 64. France Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 65. France Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 66. Italy Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 67. Italy Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 68. Italy Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 69. United Kingdom Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 70. United Kingdom Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 71. United Kingdom Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 72. Netherlands Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 73. Netherlands Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 74. Netherlands Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 75. Rest of Europe Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 76. Rest of Europe Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 77. Rest of Europe Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 78. MEA Peripheral Artery Disease, by Country USD Million (2015-2020)
  • Table 79. MEA Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 80. MEA Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 81. MEA Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 82. Middle East Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 83. Middle East Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 84. Middle East Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 85. Africa Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 86. Africa Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 87. Africa Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 88. North America Peripheral Artery Disease, by Country USD Million (2015-2020)
  • Table 89. North America Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 90. North America Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 91. North America Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 92. United States Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 93. United States Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 94. United States Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 95. Canada Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 96. Canada Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 97. Canada Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 98. Mexico Peripheral Artery Disease, by Type USD Million (2015-2020)
  • Table 99. Mexico Peripheral Artery Disease, by Filters USD Million (2015-2020)
  • Table 100. Mexico Peripheral Artery Disease, by End User USD Million (2015-2020)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Peripheral Artery Disease: by Type(USD Million)
  • Table 112. Peripheral Artery Disease Peripheral Angioplasty Balloons, , by Region USD Million (2021-2026)
  • Table 113. Peripheral Artery Disease Peripheral Stents, , by Region USD Million (2021-2026)
  • Table 114. Peripheral Artery Disease Peripheral Catheters, , by Region USD Million (2021-2026)
  • Table 115. Peripheral Artery Disease Inferior Vena Cava (IVC) , by Region USD Million (2021-2026)
  • Table 116. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2021-2026)
  • Table 117. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2021-2026)
  • Table 118. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2021-2026)
  • Table 119. Peripheral Artery Disease Balloon Inflation Devices , by Region USD Million (2021-2026)
  • Table 120. Peripheral Artery Disease: by Filters(USD Million)
  • Table 121. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2021-2026)
  • Table 122. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2021-2026)
  • Table 123. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2021-2026)
  • Table 124. Peripheral Artery Disease: by End User(USD Million)
  • Table 125. Peripheral Artery Disease Hospitals , by Region USD Million (2021-2026)
  • Table 126. Peripheral Artery Disease Clinics , by Region USD Million (2021-2026)
  • Table 127. Peripheral Artery Disease Others , by Region USD Million (2021-2026)
  • Table 128. South America Peripheral Artery Disease, by Country USD Million (2021-2026)
  • Table 129. South America Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 130. South America Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 131. South America Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 132. Brazil Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 133. Brazil Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 134. Brazil Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 135. Argentina Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 136. Argentina Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 137. Argentina Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 138. Rest of South America Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 139. Rest of South America Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 140. Rest of South America Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 141. Asia Pacific Peripheral Artery Disease, by Country USD Million (2021-2026)
  • Table 142. Asia Pacific Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 143. Asia Pacific Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 144. Asia Pacific Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 145. China Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 146. China Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 147. China Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 148. Japan Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 149. Japan Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 150. Japan Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 151. India Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 152. India Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 153. India Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 154. South Korea Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 155. South Korea Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 156. South Korea Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 157. Taiwan Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 158. Taiwan Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 159. Taiwan Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 160. Australia Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 161. Australia Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 162. Australia Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 165. Rest of Asia-Pacific Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 166. Europe Peripheral Artery Disease, by Country USD Million (2021-2026)
  • Table 167. Europe Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 168. Europe Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 169. Europe Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 170. Germany Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 171. Germany Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 172. Germany Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 173. France Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 174. France Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 175. France Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 176. Italy Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 177. Italy Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 178. Italy Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 179. United Kingdom Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 180. United Kingdom Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 181. United Kingdom Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 182. Netherlands Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 183. Netherlands Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 184. Netherlands Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 185. Rest of Europe Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 186. Rest of Europe Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 187. Rest of Europe Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 188. MEA Peripheral Artery Disease, by Country USD Million (2021-2026)
  • Table 189. MEA Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 190. MEA Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 191. MEA Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 192. Middle East Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 193. Middle East Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 194. Middle East Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 195. Africa Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 196. Africa Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 197. Africa Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 198. North America Peripheral Artery Disease, by Country USD Million (2021-2026)
  • Table 199. North America Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 200. North America Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 201. North America Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 202. United States Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 203. United States Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 204. United States Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 205. Canada Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 206. Canada Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 207. Canada Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 208. Mexico Peripheral Artery Disease, by Type USD Million (2021-2026)
  • Table 209. Mexico Peripheral Artery Disease, by Filters USD Million (2021-2026)
  • Table 210. Mexico Peripheral Artery Disease, by End User USD Million (2021-2026)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Peripheral Artery Disease: by Type USD Million (2015-2020)
  • Figure 5. Global Peripheral Artery Disease: by Filters USD Million (2015-2020)
  • Figure 6. Global Peripheral Artery Disease: by End User USD Million (2015-2020)
  • Figure 7. South America Peripheral Artery Disease Share (%), by Country
  • Figure 8. Asia Pacific Peripheral Artery Disease Share (%), by Country
  • Figure 9. Europe Peripheral Artery Disease Share (%), by Country
  • Figure 10. MEA Peripheral Artery Disease Share (%), by Country
  • Figure 11. North America Peripheral Artery Disease Share (%), by Country
  • Figure 12. Global Peripheral Artery Disease share by Players 2020 (%)
  • Figure 13. Global Peripheral Artery Disease share by Players (Top 3) 2020(%)
  • Figure 14. Global Peripheral Artery Disease share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 18. AngioDynamics (United States) Revenue, Net Income and Gross profit
  • Figure 19. AngioDynamics (United States) Revenue: by Geography 2020
  • Figure 20. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 22. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 23. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 24. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 26. BIOTRONIK (Germany) Revenue, Net Income and Gross profit
  • Figure 27. BIOTRONIK (Germany) Revenue: by Geography 2020
  • Figure 28. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cook Medical (United States) Revenue: by Geography 2020
  • Figure 30. Cardinal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cardinal Health, Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Koninklijke Philips N.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 33. Koninklijke Philips N.V (Netherlands) Revenue: by Geography 2020
  • Figure 34. TERUMO CORPORATION. (Japan) Revenue, Net Income and Gross profit
  • Figure 35. TERUMO CORPORATION. (Japan) Revenue: by Geography 2020
  • Figure 36. Global Peripheral Artery Disease: by Type USD Million (2021-2026)
  • Figure 37. Global Peripheral Artery Disease: by Filters USD Million (2021-2026)
  • Figure 38. Global Peripheral Artery Disease: by End User USD Million (2021-2026)
  • Figure 39. South America Peripheral Artery Disease Share (%), by Country
  • Figure 40. Asia Pacific Peripheral Artery Disease Share (%), by Country
  • Figure 41. Europe Peripheral Artery Disease Share (%), by Country
  • Figure 42. MEA Peripheral Artery Disease Share (%), by Country
  • Figure 43. North America Peripheral Artery Disease Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • AngioDynamics (United States)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (United States)
  • Boston Scientific Corporation (United States)
  • BIOTRONIK (Germany)
  • Cook Medical (United States)
  • Cardinal Health, Inc. (United States)
  • Koninklijke Philips N.V (Netherlands)
  • TERUMO CORPORATION. (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation